Reproduction/Androgen Disorders News

CHICAGO — Hormone therapy use among menopausal women has fallen to just 1.8% as of 2023, data show, despite evidence and clinical guidance suggesting HT is safe and effective for most women for bothersome menopausal symptoms.

Some types of endocrine-disrupting chemicals may act as kisspeptin or gonadotropin-releasing hormone receptor agonists and could induce early puberty for children, according to in vitro findings published in Endocrinology.

A lack of menopause education for health care professionals has had a direct impact on midlife women seeking care, and a new initiative from The Menopause Society aims to bridge a wide gap in knowledge and training.

Preexisting diabetes was associated with a more than tripled odds of experiencing stillbirth or perinatal mortality, with higher risks for mothers with type 2 vs. type 1 diabetes, researchers reported in Obstetrics & Gynecology.

Women with polycystic ovary syndrome and high androgen levels may have a higher risk for liver disease than those with PCOS and normal androgen levels, according to an analysis of UK Biobank data.

Interpregnancy intervals of 24 months or longer were associated with higher risk for gestational diabetes in later pregnancies, independent of maternal age, researchers reported in BMC Pregnancy and Childbirth.

Polycystic ovary syndrome presents in many forms with many manifestations, which is why providers must work with patients to treat the condition while factoring in their preferences and top concerns.

Fidelma Dunne, MD, PhD, FRCP, FRCPI, describes herself as a wife, mother, grandmother, sister and daughter who draws satisfaction from her family and from her career in endocrinology.

The past 10 years have seen rapid growth in research on how endocrine-disrupting chemicals affect humans.